Medison Ventures

Medison Ventures’ edge lies in access to over twenty years of clinical and commercial know-how accumulated by Medison Pharma , our parent company. We build proprietary deal-flow generating platforms, that are designed to identify and execute on opportunities that hold the potential to inject value to Medison and its partners.

ABOUT MEDISON

Medison Ventures is the corporate venture arm of Medison Pharma.

Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets.

Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments accessible to patients in international markets.

Medison has a track record of multi-territorial partnerships with leading pharmaceutical and biotech companies seeking to expand their global reach.

Medison Ventures is the corporate venture arm of Medison, a global pharma company providing access to highly innovative therapies to patients in international markets. Our passion is to seek and grow cutting edge innovations in biotech and digital health, which are designed to transform patients’ lives.

TRANSFORMATIVE HEALTHCARE

INNOVATION IS OUR NORTH STAR

Our holistic exposure to stakeholders across the spectrum is made possible through both eye-level relationships and an unprecedented access to Medison’s network. We fully immerse ourselves in the world of healthcare. We walk the hallways of academia and medical centers, listen to patients, engage with our global pharma partners, and meet with key opinion leaders.

With a rounded, patient-centric, industry-informed perspective, we search for and evaluate breakthrough technologies across various stages of development, prior to constructing an independent notion of both the problems being solved and the proposed solutions. Having assessed the industry’s willingness to adopt specific innovative solutions, we leverage strategic alliances and our investment vehicles to inject value into these innovative projects.

We seek highly innovative products at advanced stages of development to in-license and commercialize in the territories covered by Medison.

We view ourselves as ‘external R&D’ for Medison’s global partners. Each year, hundreds of projects are funneled into Medison Ventures via our team and global network. Our continuous research and evaluation is informed by a deep understanding and appreciation of each partners’ specific needs, allowing us to find tailored opportunities to further drive their pipeline needs and long-term vision.

Leveraging over two decades of clinical and commercial expertise from its parent company, Medison Ventures identifies and executes opportunities that add value to both Medison and its partners. The firm immerses itself in the healthcare ecosystem by engaging with academia, medical centers, patients, global pharma partners, and key opinion leaders. This comprehensive approach enables Medison Ventures to evaluate breakthrough technologies across various development stages and assess industry adoption readiness.

Medison Ventures has made notable investments in companies such as Alpha Tau Medical, Orchard Therapeutics, and Allogene Therapeutics, focusing on sectors like biotechnology and drug discovery.

Through its strategic alliances and investment vehicles, Medison Ventures seeks highly innovative products at advanced development stages for in-licensing and commercialization within Medison's covered territories. By acting as 'external R&D' for its global partners, the firm continuously researches and evaluates opportunities tailored to meet specific partner needs, driving pipeline growth and supporting long-term visions.

Medison Ventures

Medison Ventures catalyzes breakthroughs in life sciences. We invest across Medison Medicine and Medison Pharma projects worldwide, partnering with startups and established leaders to accelerate the development of novel therapies.

Medison Medicine

Medison Medicine sources, develops and distributes a diverse portfolio of high‑quality pharmaceuticals. From specialty injectables to oral therapies, Medison Medicine delivers patient‑focused solutions to hospitals, clinics and pharmacies everywhere.

Medison Pharma

Under Medison Pharma, our R&D teams drive cutting‑edge drug discovery and formulation. Expert chemists, biologists and clinicians ensure each Medison Pharma candidate meets the highest standards of safety, efficacy and manufacturability.

Medison Pharma Canada

Medison Pharma Canada brings our global research and development to North America. Based in Toronto, our Canadian hub accelerates clinical trials, regulatory filings and collaborations with top healthcare institutions across Canada.

Medison Canada

Through Medison Canada, we support community health programs, educational grants and biotech partnerships. Medison Canada fosters local innovation from accelerator grants to hospital outreach—strengthening Canada’s role in global healthcare.

Our Approach

We operate as a bridge between innovation and impact, leveraging our expertise and global reach to bring transformative therapies to markets worldwide. By acting as an external R&D arm for our partners, we ensure that the most promising innovations reach patients who need them most.

Our Mission

Our mission is to identify, invest in, and support breakthrough biotech and digital health innovations that have the potential to revolutionize patient care and redefine therapeutic boundaries.

Strategic Investments :

We partner with visionary entrepreneurs and scientists, investing in early-to-late-stage life sciences and digital health companies.

Global Commercial Expertise :

Backed by Medison Pharma's decades of experience, we bring unparalleled market knowledge to guide innovations from lab to market.

Collaborative Ecosystem :

We engage with a diverse network of academic institutions, healthcare providers, and industry leaders to evaluate and nurture transformative healthcare solutions.